AllianceBernstein
PRCT icon

AllianceBernstein’s Procept Biorobotics PRCT Stock Holding History

AllianceBernstein’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.63M Sell
147,327
-3,238,095
-96% -$91.3M ﹤0.01% 1573
2025
Q4 		$107M Sell
3,385,422
-34,362
-1% -$1.14M 0.03% 372
2025
Q3 		$122M Buy
3,419,784
+1,262,928
+59% +$57.7M 0.04% 334
2025
Q2 		$124M Buy
2,156,856
+13,163
+0.6% +$744K 0.04% 318
2025
Q1 		$125M Buy
2,143,693
+391,215
+22% +$26.7M 0.05% 303
2024
Q4 		$141M Buy
1,752,478
+218,148
+14% +$18.6M 0.05% 302
2024
Q3 		$123M Sell
1,534,330
-274,824
-15% -$19.5M 0.04% 344
2024
Q2 		$111M Sell
1,809,154
-176,663
-9% -$10.5M 0.04% 360
2024
Q1 		$98.1M Sell
1,985,817
-70,533
-3% -$3.36M 0.03% 409
2023
Q4 		$86.2M Buy
2,056,350
+1,459,365
+244% +$49.7M 0.03% 445
2023
Q3 		$19.6M Buy
596,985
+559,035
+1,473% +$19.1M 0.01% 847
2023
Q2 		$1.34M Buy
37,950
+12,850
+51% +$425K ﹤0.01% 2118
2023
Q1 		$713K Hold
25,100
– – ﹤0.01% 2387
2022
Q4 		$1.04M Hold
25,100
– – ﹤0.01% 2249
2022
Q3 		$1.04M Hold
25,100
– – ﹤0.01% 2266
2022
Q2 		$821K Buy
+25,100
New +$913K ﹤0.01% 2449

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein's PRCT Position: Q1 2026 in Review

AllianceBernstein reduced its Procept Biorobotics (PRCT) stake by 96% in Q1 2026, selling an estimated $91.3M and leaving 147,327 shares worth $4.63M. The position accounts for ﹤0.01% of the portfolio, ranked #1573.

AllianceBernstein first reported a position in PRCT in Q2 2022 and has held it in 16 quarters since. The position peaked at $141M in Q4 2024. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • AllianceBernstein held 147,327 shares of Procept Biorobotics worth $4.63M as of Q1 2026.
  • AllianceBernstein sold 3,238,095 Procept Biorobotics shares in Q1 2026, an estimated $91.3M.
  • Procept Biorobotics made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #1573 holding.
  • AllianceBernstein first reported a position in Procept Biorobotics in Q2 2022 and has held it in 16 quarters since.
  • AllianceBernstein's Procept Biorobotics position peaked at $141M in Q4 2024.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.